On November 11, 2026 INOVIO (NASDAQ: INO), a commercial-stage biotechnology company focused on developing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, reported that it will participate in the following investor conferences:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies Global Healthcare Conference in London
Date: Wednesday, November 18
Time: 12:00 p.m. EST / 5:00 p.m. GMT
Format: Presentation
Webcast: https://event.summitcast.com/view/avibSrFufLKeoLRAEgMxy6/e3gFZPzHNgoxtsxeAwXEr2
Piper Sandler 38th Annual Healthcare Conference in New York
Date: Tuesday, December 1
Time: 2:00-2:25 p.m. EST
Format: Fireside chat
Webcast: View Source;tp_key=9cacd40318
Replays of the presentations will be available for 90 days at the links above. During these conferences members of INOVIO’s management team will also be conducting one-on-one meetings with investors.
(Press release, Inovio, NOV 11, 2026, View Source [SID1234674605])